Bayer HealthCare AG - Product Pipeline Analysis

Bayer HealthCare AG - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide50 Pages Price :
$ 750

Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group is a healthcare company. It undertakes the design, research, development, manufacture and sale of medical products for the healthcare industry. The company develops innovative products such as animal healthcare products, consumer care products, blood glucose monitoring systems, diagnostic imaging products, oncology products and primary care products. It operates through four business divisions, namely, Animal Health, Consumer Care, Medical Care and Pharmaceuticals. Bayer Healthcares products are marketed across the world through regional and national distribution companies. It operates in more than 100 countries and has about 60 manufacturing facilities across five continents. The company is headquartered in Leverkusen, Germany.

Bayer Healthcare focuses on enhancing its market share through strategic alliances and acquisitions. In line with this strategy, the company recently collaborated with Covance; and acquired animal health business of KMG Chemicals.

This report is a source for data, analysis and actionable intelligence on the Bayer HealthCare AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5

Bayer HealthCare AG - Business Description 6

Key Facts 7
Bayer HealthCare AG - Major Products and Services 8
Bayer HealthCare AG Pipeline Products by Equipment Type 10
Bayer HealthCare AG Pipeline Products by Development Stage 12
Bayer HealthCare AG Pipeline Products by Therapy Area 14
Bayer HealthCare AG Pipeline Products by Trial Phase 16
Bayer HealthCare AG Pipeline Products by Milestone Summary 18
Bayer Blood Glucose Monitoring System 20
Bayer Blood Glucose Monitoring System Product Status 20
Bayer Blood Glucose Monitoring System Product Description 20
Ciprofloxacin Dry Powder Inhaler 21
Ciprofloxacin Dry Powder Inhaler Product Status 21
Ciprofloxacin Dry Powder Inhaler Product Description 21
Ciprofloxacin Dry Powder Inhaler Product Patent Details 21
CONTOUR Next EZ Blood Glucose Monitoring System 22
CONTOUR Next EZ Blood Glucose Monitoring System Product Status 22
CONTOUR Next EZ Blood Glucose Monitoring System Product Description 22
CONTOUR Next EZ Blood Glucose Monitoring System Product Milestone 22
CONTOUR Next EZ Blood Glucose Monitoring System Clinical Trial 24
Contrast Agent Injection System 25
Contrast Agent Injection System Product Status 25
Contrast Agent Injection System Product Description 25
FC Patch Low 26
FC Patch Low Product Status 26
FC Patch Low Product Description 26
FC Patch Low Product Milestone 26
FC Patch Low Clinical Trial 27
LCS-12 31
LCS-12 Product Status 31
LCS-12 Product Description 31
LCS-12 Product Milestone 31
LCS-16 32
LCS-16 Product Status 32
LCS-16 Product Description 32
Silica Gel Wound Dressing 33
Silica Gel Wound Dressing Product Status 33
Silica Gel Wound Dressing Product Description 33
Silica Gel Wound Dressing Product Milestone 33
Silica Gel Wound Dressing Clinical Trial 34
Thrombectomy System 37
Thrombectomy System Product Status 37
Thrombectomy System Product Description 37
Bayer HealthCare AG - Key Competitors 38
Bayer HealthCare AG - Key Employees 39
Bayer HealthCare AG - Key Employee Biographies 40
Bayer HealthCare AG - Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 43
Bayer HealthCare AG, Recent Developments 43
Jul 10, 2012: Bayer Announces 2012 Recipients Of Bayer Hemophilia Awards Program 43
Jul 02, 2012: Bayer To Present Data On Hemophilia Research At WFH 2012 World Congress 43
Mar 28, 2012: Bayer To Present New Data On Oncology Pipeline 44
Jan 27, 2012: Bayer Receives Approval From EU Authorities To Use Gadovist 1.0 In Children Aged Two Years And Older 45
Jan 19, 2012: Bayer HealthCare Expands Research And Manufacturing Capabilities For Interventional Franchise 46
Jan 09, 2012: Bayer HealthCare To Share Lab Space With Start-Up Companies 46
Jan 04, 2012: Intendis Changes Name To Bayer HealthCare 47
Aug 15, 2011: Bayer To Support WHO And Stop Tuberculosis Partnership In Fighting Tuberculosis 47
Apr 04, 2011: Bayer HealthCare Selects State Of New Jersey For East Coast Site Consolidation 47
Apr 01, 2011: Bayer To Present Data On Oncology Pipeline 48

Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Table


Bayer HealthCare AG, Key Facts 1
Bayer HealthCare AG Key Pipeline Products by Equipment Type 1
Bayer HealthCare AG Key Pipeline Products by Therapy Area 1
Bayer HealthCare AG Key Pipeline Products by Development Stage 1
Bayer HealthCare AG Key Pipeline Products by Trial Phase 1
Bayer HealthCare AG, Key Facts 7
Bayer HealthCare AG, Major Products and Services 8
Bayer HealthCare AG Number of Pipeline Products by Equipment Type 10
Bayer HealthCare AG Pipeline Products by Equipment Type 11
Bayer HealthCare AG Number of Pipeline Products by Development Stage 12
Bayer HealthCare AG Pipeline Products by Development Stage 13
Bayer HealthCare AG Number of Pipeline Products by Therapy Area 14
Bayer HealthCare AG Pipeline Products by Therapy Area 15
Bayer HealthCare AG Number of Pipeline Products by Trial Phase 16
Bayer HealthCare AG Pipeline Products by Trial Phase 17
Bayer HealthCare AG Number of Pipeline Products By Milestone Summary 18
Bayer HealthCare AG Pipeline Products by Milestone Summary 19
Bayer Blood Glucose Monitoring System - Product Status 20
Bayer Blood Glucose Monitoring System - Product Description 20
Ciprofloxacin Dry Powder Inhaler - Product Status 21
Ciprofloxacin Dry Powder Inhaler - Product Description 21
Ciprofloxacin Dry Powder Inhaler - Patent Details1 21
CONTOUR Next EZ Blood Glucose Monitoring System - Product Status 22
CONTOUR Next EZ Blood Glucose Monitoring System - Product Description 22
CONTOUR Next EZ Blood Glucose Monitoring System - Product Milestone 22
CONTOUR Next EZ Blood Glucose Monitoring System - A Clinical Trial Evaluating the Use of the CONTOUR Next EZ BGM System 24
Contrast Agent Injection System - Product Status 25
Contrast Agent Injection System - Product Description 25
FC Patch Low - Product Status 26
FC Patch Low - Product Description 26
FC Patch Low - Product Milestone 26
FC Patch Low - Multi-Center, Open, Randomized, Parallel Group Comparison of Cycle Control for Seven Cycles and Endometrial Safety in a Subgroup for Thirteen Cycles of Contraceptive Patch SH P00331F ( vs a Contraceptive Comparator Patch in 400 Healthy Female Volunteers) 27
FC Patch Low - A Single-Center, Open-Label, Crossover, Randomized Study to Investigate the Impact of the Transdermal Contraceptive Patch 28
FC Patch Low - Transdermal Contraception Patch: EU Cycle Control Study Versus EVRA 29
LCS-12 - Product Status 31
LCS-12 - Product Description 31
LCS-12 - Product Milestone 31
LCS-16 - Product Status 32
LCS-16 - Product Description 32
Silica Gel Wound Dressing - Product Status 33
Silica Gel Wound Dressing - Product Description 33
Silica Gel Wound Dressing - Product Milestone 33
Silica Gel Wound Dressing - Clinical Trial to Evaluate Silica Gel Wound Dressing in Patients Suffering from Chronic Venous Leg Ulcers 34
Silica Gel Wound Dressing - Randomized Standard-of-Care-Controlled Trial of a Silica Gel Fiber (SGF) Wound Dressing in the Treatment of Chronic Venous Leg Ulcers 35
Thrombectomy System - Product Status 37
Thrombectomy System - Product Description 37
Bayer HealthCare AG, Key Employees 39
Bayer HealthCare AG, Key Employee Biographies 40
Bayer HealthCare AG, Other Locations 41
Bayer HealthCare AG, Subsidiaries 42

List of Chart


Bayer HealthCare AG Key Pipeline Products by Equipment Type 1
Bayer HealthCare AG Pipeline Products by Equipment Type 10
Bayer HealthCare AG Pipeline Products by Development Stage 12
Bayer HealthCare AG Pipeline Products by Therapy Area 14
Bayer HealthCare AG Pipeline Products by Trial Phase 16
Bayer HealthCare AG Pipeline Products by Milestone Summary 18

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top